ISpecimen Operating Margin 2020-2025 | ISPC
Current and historical operating margin for ISpecimen (ISPC) over the last 10 years. The current operating profit margin for ISpecimen as of March 31, 2025 is -139.63%.
| ISpecimen Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $0.01B | $-0.01B | -150.00% |
| 2024-12-31 | $0.01B | $-0.01B | -144.44% |
| 2024-09-30 | $0.01B | $-0.01B | -90.91% |
| 2024-06-30 | $0.01B | $-0.01B | -90.91% |
| 2024-03-31 | $0.01B | $-0.01B | -120.00% |
| 2023-12-31 | $0.01B | $-0.01B | -109.09% |
| 2023-09-30 | $0.01B | $-0.01B | -100.00% |
| 2023-06-30 | $0.01B | $-0.01B | -109.09% |
| 2023-03-31 | $0.01B | $-0.01B | -100.00% |
| 2022-12-31 | $0.01B | $-0.01B | -90.91% |
| 2022-09-30 | $0.01B | $-0.01B | -90.91% |
| 2022-06-30 | $0.01B | $-0.01B | -72.73% |
| 2022-03-31 | $0.01B | $-0.01B | -58.33% |
| 2021-12-31 | $0.01B | $-0.01B | -50.00% |
| 2021-06-30 | $0.01B | $0.00B | -50.00% |
| 2021-03-31 | $0.01B | $0.00B | -28.57% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.003B | $0.009B |
| iSpecimen Inc. offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers which have access to patients and specimens needed for medical discovery. iSpecimen Inc. is based in LEXINGTON, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.306B | 27.32 |
| CVS Health (CVS) | United States | $83.088B | 10.33 |
| Elevance Health (ELV) | United States | $65.860B | 8.86 |
| Cencora (COR) | United States | $56.044B | 18.67 |
| DiDi Global (DIDIY) | China | $26.733B | 28.40 |
| Labcorp Holdings (LH) | United States | $22.380B | 17.79 |
| Natera (NTRA) | United States | $21.934B | 0.00 |
| BioMerieux (BMXMF) | France | $17.238B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.271B | 0.00 |
| ICON (ICLR) | Ireland | $13.654B | 13.14 |
| CochLear (CHEOY) | Australia | $13.302B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.903B | 34.15 |
| Solventum (SOLV) | United States | $12.500B | 12.90 |
| Viatris (VTRS) | United States | $11.799B | 4.20 |
| Revvity (RVTY) | United States | $10.214B | 18.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.176B | 0.00 |
| Avantor (AVTR) | United States | $8.631B | 12.66 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.258B | 0.00 |
| HealthEquity (HQY) | United States | $8.040B | 35.22 |
| Charles River Laboratories (CRL) | United States | $7.517B | 14.26 |
| Bausch + Lomb (BLCO) | Canada | $4.874B | 32.79 |
| Sotera Health (SHC) | United States | $4.221B | 23.59 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| BrightSpring Health Services (BTSG) | United States | $3.848B | 29.35 |
| GeneDx Holdings (WGS) | United States | $3.344B | 76.59 |
| Surgery Partners (SGRY) | United States | $2.946B | 37.06 |
| Alignment Healthcare (ALHC) | United States | $2.899B | 0.00 |
| Concentras Parent (CON) | United States | $2.871B | 18.21 |
| Organon (OGN) | United States | $2.353B | 2.56 |
| Premier (PINC) | United States | $1.978B | 15.01 |
| Progyny (PGNY) | United States | $1.873B | 39.60 |
| Ardent Health (ARDT) | United States | $1.785B | 6.89 |
| PACS (PACS) | United States | $1.705B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.282B | 8.56 |
| GoodRx Holdings (GDRX) | United States | $1.250B | 20.59 |
| Teladoc Health (TDOC) | United States | $1.214B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.974B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.779B | 4.56 |
| AMN Healthcare Services Inc (AMN) | United States | $0.676B | 8.36 |
| CareDx (CDNA) | United States | $0.663B | 12.22 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 200.00 |
| Nutex Health (NUTX) | United States | $0.534B | 8.08 |
| Omada Health (OMDA) | $0.497B | 0.00 | |
| So-Young (SY) | China | $0.488B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.485B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.480B | 0.00 |
| SBC Medicals (SBC) | United States | $0.470B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 10.52 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 25.13 |
| Agilon Health (AGL) | United States | $0.369B | 0.00 |
| Oncology Institute (TOI) | United States | $0.367B | 0.00 |
| LifeMD (LFMD) | United States | $0.324B | 0.00 |
| Beauty Health (SKIN) | United States | $0.292B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.169B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.129B | 0.00 |
| KindlyMD (NAKA) | United States | $0.084B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.084B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
| ModivCare (MODV) | United States | $0.033B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |